Exact Mass: 686.3335804000001

Exact Mass Matches: 686.3335804000001

Found 23 metabolites which its exact mass value is equals to given mass value 686.3335804000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dslet

(D-Ser2)-Leu-Enkephalin-Thr

C33H46N6O10 (686.3275256000001)

D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins

Dslet

2-[(2-{[2-({2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1,3-dihydroxypropylidene)amino]-1-hydroxyethylidene}amino)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-3-hydroxybutanoate

C33H46N6O10 (686.3275256000001)

PG-PI

1-hexadecanoyl-2-glutaryl-sn-glycero-3-phospho-(1-myo-inositol)

C30H55O15P (686.3278409999999)

Tetrakis[[2,2,2-nitrilotris[ethanolato]](1-)-N,o]zirconium

C24H60N4O12Zr (686.32546)

1,3-Di-HABA Kanamycin A

C26H50N6O15 (686.333399)

2-[2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-acetylamino)-3-phenyl-propionylamino]-4-methyl-pentanoic acid

C33H46N6O10 (686.3275256000001)

2-[3-(2-Tert-butyl-9-ethyl-6,8,8-trimethyl-8,9-dihydropyrano[3,2-g]quinolin-1-ium-4-yl)prop-2-en-1-ylidene]-1-(5-carboxypentyl)-3,3-dimethylindoline-5-sulfonate

C40H50N2O6S (686.3389400000001)

Smgdg O-22:6_3:0

C34H54O12S (686.3335804000001)

SMGDG O-25:6

C34H54O12S (686.3335804000001)

SQDG 25:5

C34H54O12S (686.3335804000001)

PG 20:3/8:3;O2

C34H55O12P (686.343096)

PG 20:4/8:2;O2

C34H55O12P (686.343096)

PG 20:5/8:1;O2

C34H55O12P (686.343096)

PG 28:6;O2

C34H55O12P (686.343096)

PI 16:0/5:1;O2

C30H55O15P (686.3278409999999)

PI 21:1;O2

C30H55O15P (686.3278409999999)

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3bs,5s,5as,7s,9as,11as)-9a,11a-dimethyl-1-[(1s)-1-[(2s,3s)-3-[(2r)-3-methylbutan-2-yl]oxiran-2-yl]ethyl]-5-(sulfooxy)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3bs,5s,5as,7s,9as,11as)-9a,11a-dimethyl-1-[(1s)-1-[(2s,3s)-3-[(2r)-3-methylbutan-2-yl]oxiran-2-yl]ethyl]-5-(sulfooxy)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C34H54O12S (686.3335804000001)

(1r,4r,5r,7s,8r,9r,10r,11s,12s)-5,7-bis(acetyloxy)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl 2-methylpropanoate

(1r,4r,5r,7s,8r,9r,10r,11s,12s)-5,7-bis(acetyloxy)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl 2-methylpropanoate

C37H50O12 (686.3302100000001)